An Nvidia logo can be seen on the company building in an industrial park on February 7, 2019 in Tianjin, China.
VCG | Visual China Group | Getty Images
CureVac – The German biopharmaceutical company’s shares continued to fall after primary efficacy results were released on Wednesday for its Covid-19 vaccine candidate, which showed preliminary efficacy of only 47%. The stock closed 39% on Thursday.
Novavax – Novavax shares rose 2% after CureVac reported disappointing results from a study on its Covid-19 vaccine. Novavax said on Monday its Covid vaccine was 90% effective.
The Honest Company – The Honest Company’s stock fell 7.37% after the baby and beauty business’s initial earnings report. The company had revenue of $ 81.0 million for the first quarter, compared to analyst estimates of $ 79.3 million, according to Refinitiv. Guggenheim downgraded the stock from Buy to neutral. “While we remain positive on the underlying fundamental outlook, we believe we are downgrading the stock to neutral due to the more balanced risk / reward ratio and lack of an obvious catalyst to significantly raise our sales expectations or our valuation multiple,” said Guggenheim said.
Nvidia – Nvidia shares rose 4.7% after Jefferies raised its target price on the semiconductor stock to a Wall Street high of $ 712.41. “We see NVDA as one of the main beneficiaries of the fourth tectonic shift in computing, with parallel processing gaining a share of the computing market,” said Jefferies’ Mark Lipacis. “We believe NVDA’s decades of investment in CUDA have resulted in multi-year competitive advantage.”
Lennar – The housing company’s shares were up 3.6%. On Wednesday, Lennar reported earnings of $ 2.65 per share, according to Refinitiv, beating estimates of $ 2.36 per share. The company is grappling with higher production costs and a labor shortage, but the shortage of homes for sale in the U.S. helped raise prices and significantly increase Lennar’s profit margins year over year.
Danaher – The medical device maker’s stock rose about 4.5% after it was announced it would buy privately held biotech company Aldevron for $ 9.6 billion in a cash-only deal. Aldevron produces plasmid DNA, mRNA and proteins to support biotechnology and pharmaceutical customers and has a contract with Moderna to supply plasmid DNA, a requirement for making vaccines.
Kroger – The supermarket chain’s stock rose over 5% after reporting earnings, raising its earnings forecast, and making buybacks. Kroger reported earnings per share of $ 1.19, beating analyst estimates by 19% and revenue of $ 41.3 billion.
Fisker – The auto company’s shares rose more than 3% after signing a long-term manufacturing agreement with Magna International. Production of the SUV Fisker Ocean is scheduled to begin in November 2022 at the climate-neutral Magna plant in Graz, Austria.
– CNBC’s Hannah Miao and Maggie Fitzgerald contributed to the coverage
Become a smarter investor with CNBC Pro.
Get stock picks, analyst calls, exclusive interviews and access to CNBC TV.
Sign in to one. to start Try it for free today